Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 572Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 16Elanco, Division Eli Lilly Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Spinosyn D

Brand Name : COMFORTIS

Patent Number : 2379329

Filing Date : 2000-08-02

Strength per Unit : 140 mg

Dosage Form : Tablets

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2020-08-02

Date Granted : 2009-10-20

blank

02

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Spinosyn D

Brand Name : COMFORTIS

Patent Number : 2379329

Filing Date : 2000-08-02

Strength per Unit : 270 mg

Dosage Form : Tablets

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2020-08-02

Date Granted : 2009-10-20

blank

03

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Spinosyn D

Brand Name : COMFORTIS

Patent Number : 2379329

Filing Date : 2000-08-02

Strength per Unit : 560 mg

Dosage Form : Tablets

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2020-08-02

Date Granted : 2009-10-20

blank

04

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Spinosyn D

Brand Name : COMFORTIS

Patent Number : 2379329

Filing Date : 2000-08-02

Strength per Unit : 810 mg

Dosage Form : Chewable Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2020-08-02

Date Granted : 2009-10-20

blank

05

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Spinosyn D

Brand Name : COMFORTIS

Patent Number : 2379329

Filing Date : 2000-08-02

Strength per Unit : 1620 mg

Dosage Form : Chewable Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2020-08-02

Date Granted : 2009-10-20

blank

06

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Spinosyn D, Milbemycin Oxime

Brand Name : TRIFEXIS

Patent Number : 2460692

Filing Date : 2001-09-17

Strength per Unit : 140 mg / 2.3 mg

Dosage Form : Chewable Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2021-09-17

Date Granted : 2012-12-18

blank

07

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Spinosyn D, Milbemycin Oxime

Brand Name : TRIFEXIS

Patent Number : 2460692

Filing Date : 2001-09-17

Strength per Unit : 270 mg / 4.5 mg

Dosage Form : Chewable Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2021-09-17

Date Granted : 2012-12-18

blank

08

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Spinosyn D, Milbemycin Oxime

Brand Name : TRIFEXIS

Patent Number : 2460692

Filing Date : 2001-09-17

Strength per Unit : 560 mg / 9.3 mg

Dosage Form : Chewable Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2021-09-17

Date Granted : 2012-12-18

blank

09

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Spinosyn D

Brand Name : COMFORTIS

Patent Number : 2379329

Filing Date : 2000-08-02

Strength per Unit : 90 mg

Dosage Form : Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2020-08-02

Date Granted : 2009-10-20

blank

10

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Spinosyn D, Milbemycin Oxime

Brand Name : TRIFEXIS

Patent Number : 2379329

Filing Date : 2000-08-02

Strength per Unit : 140 mg / 2.3 mg

Dosage Form : Chewable Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2020-08-02

Date Granted : 2009-10-20

blank